AI Strategic Blueprint for BioPharma
Creating an organization that strategically leverages AI to inform strategic decision-making, increase efficiency and drive growth
Achieve measurable and impactful business growth in pharmaceuticals with AI.
Get a unique AI-enabled strategy to identify growth opportunities that deliver impact
AI is transforming the pharmaceutical industry. Those who can strategically implement AI into their organization will realize exponential results and be able to maintain that in the changing future. Organizations that have AI strategically positioned at the core of their business and built into their DNA will be set up for success now and in the future.
We have a data science and IT Team – isn’t that enough?
Most pharma have already got strong AI/data science capacity in-house. This alone is not enough – although it will be useful for the execution phase. The challenge in most pharma companies with strong AI/data science teams is that the business leaders do not always know the depth of what is possible, and the data science teams are not business strategists.
The reality in most pharma
Currently in most pharma, there is some automation and AI projects but there are no specific identified AI goals that align with the corporate and business unit goals, and no blueprint to achieve them. Companies that do AI in an ad hoc way rarely achieve their goals.
To achieve impact with AI, strategy must lead
Our clients understand the importance of strategically planning the optimal AI approach to translate into business success.
Creating an organisation that strategically leverages AI to inform strategic decision-making, increase efficiency and drive growth allows you to carve out a competitive advantage, respond to changes in the market, and better serve Healthcare Professionals, Patients, Payers and Internal Stakeholders and create more impact for the company.
What do we offer?
You get a bullet-proof AI-enabled strategic blueprint that is strategically planned to align your business goals with your AI approach with generate efficiencies and growth for your organization.
Plus, you get a landscape analysis of the optimal vendors for any strategically identified AI.
We do this for biopharma boards and business unit leaders!
What can be done?
By developing a Strategic AI Blueprint you strategically aligns the corporate vision to the most impactful AI strategy to execute to achieve the vision, while being able to demonstrate that the resulting AI projects will have a strong probability of success and strong impact on the organization efficiency and impact.
Interested in achieving reliable measurable impact from AI?
If you're looking for a data-driven unique AI strategy that achieves real world results, specific to your business unit goals , we'd love to help.
Trusted by these partners and more
What you get from an AI Strategic Blueprint
Challenges you can get help planning & implementing
For Biopharma
- Identify where AI can add strategically add strong value and measurable impact within your business unit processes.
- Identify where the focus should be within these teams for strongest value to Healthcare Professionals, Patients, Payers and Internal Stakeholders while optimizing the business unit activities and the company impact.
- Define the strategy that outlines strategic opportunity spaces and clearly meets the company’s business needs and identifies the optimal strategic path leveraging artificial intelligence to value creation for Healthcare Professionals, Patients, Payers and Internal Stakeholders, the ecosystem, and company growth opportunities.
- Identify the specific high value AI projects that will add most value to the business,
- Prioritise these.
- Ensure the AI strategy connects multiple challenges to effectively solve them efficiently.
- Facilitate the execution of the vision and measurement of results.
Our framework to deliver the outcome.
Our overall framework includes three phases designed to develop a winning data-driven AI-fuelled strategy aligned with the executive team’s overall value impact strategy;
- the first of which is to identify where the strategy should focus for optimal value to the company within the chosen business units. (where to play)
- then to create a blueprint of how to translate the high-level focus into a winning strategy, with specific AI projects and evaluation of costs vs benefits and anticipated results to prioritize into the ‘must have’ initiatives and anticipated results. This will create a compelling strategic narrative that outlines the optimal steps to create the winning data-driven strategy, where future areas of value will be, and what role the data-driven will play in achieving that vision. (how to win)
- then the execution itself which may be internal or may be outsourced (execute) and for which Eularis will have made recommendations in the AI blueprint
"I worked closely with Andree and the team at Eularis on a 4-month project. Andree has the unique ability to quickly get up to speed on an organization's strategic focus and distill complex information into a simplified format that allows a leadership team to provide appropriate input and guidance. I always looked forward to our weekly calls and learned something new in every single one. She is well organized, asks insightful questions, and has a knowledge of AI and the pharmaceutical industry that is unparalleled. The output of our project was high value for our entire organization, and I look forward to working with Andree again..”
We help you every step of the way. Your success is our success. And on top of that, you and your team will stay ahead in the changing AI-powered world we are moving into.
Looking for AI strategy like this?
If you're interested in understanding more about our unique AI Strategic Blueprint for Pharma, please get in touch, and we'll be happy to discuss your needs.
Why Eularis?
At Eularis, over 20 years of condensed, tactical, and practical knowledge in pharmaceuticals and AI to deliver this well-structured program for benefiting biopharma and agencies and vendors alike.
We not only plan an AI strategy that delivers measurable impact, but we will give you the exact processes, important techniques, and monumental touchpoints that’ll put you light years ahead of your competition. And we will hold your hand every step of the way where you need us!
What this translates to is:
What this translates to is:
- Recession-proof growth
- More efficiency
- Solid business profits
- Higher revenues
And you also get Dr Andree Bates, our CEO
Dr. Andrée Bates is a leading and highly sought-after thought leader in Artificial Intelligence for Pharma and the founder and CEO of Eularis, a firm that has been focused on tackling pharma industry challenges with artificial intelligence since 2003. She has worked in applying AI in Pharma in Europe, USA, Canada, LATAM, EMEA, Japan, UK, and China since 2003.
Dr. Bates has led AI programs for numerous top-tier pharmaceutical companies in diverse areas such as R&D, clinical trials, regulatory affairs, and integrated analytics. Her work has resulted in measurable efficiency and growth in profit and market share for her clients.
Dr Bates ensures that every strategic blueprint we do is the best-in-class to date.
Ask yourself this:
- Do you want to achieve more growth from utilising AI strategically?
- Do you want to become more productive and efficient?
- Do you want to be able to scale your successful AI pilots rapidly?
- Do you want to overcome the majority of your challenges?
- Do you want to outperform your competition?
For success-focused professionals and organizations in the biopharma world, the answer to all these questions is and will always be “Yes.”